Cytosorbents Corp
CTSO
91 hedge funds and large institutions have $74.4M invested in Cytosorbents Corp in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 19 closing their positions.
308% more call options, than puts
Call options by funds: $314K | Put options by funds: $77K
3% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 29
1.44% less ownership
Funds ownership: 42.35% → 40.91% (-1.4%)
5% less funds holding
Funds holding: 96 → 91 (-5)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
50% less capital invested
Capital invested by funds: $148M → $74.4M (-$73.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Avenir Corporation
Alexandria,
Virginia
|
+$2.2M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.89M |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$959K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$701K |
| 5 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
+$611K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.5M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.99M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$1.84M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.01M |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$1.01M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$94.8K | -11,670 | Closed |
|
102
Jane Street
New York
| – | -$91K | -11,190 | Closed |
|
103
Lazard Asset Management
New York
| – | -$43K | -5,371 | Closed |
|
|
QT
104
Quantbot Technologies
New York
| – | -$34K | -4,200 | Closed |
|
105
Group One Trading
Chicago,
Illinois
| – | -$9.28K | -1,654 | Closed |
|
|
AF
106
Advisornet Financial
Minnetonka,
Minnesota
| – | -$5.61K | -1,000 | -91% |
|
|
FP
107
Financial Perspectives
Minneapolis,
Minnesota
| – | -$8.12K | -1,000 | Closed |
|
|
TCWM
108
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$4K | -521 | Closed |
|
|
LC
109
Lindbrook Capital
Calabasas,
California
| – | -$1K | -125 | Closed |
|
CTSO Hedge Fund Activity: Q4 2021 in Review
91 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2021, worth a combined $74.4M — down 50% from $148M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CTSO and 14 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 28 added.
The largest buyer was Avenir Corporation, adding an estimated $2.2M. The largest seller was Soleus Capital Management, exiting entirely with an estimated $6.5M sold.
- 91 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2021, down from 96 in Q3 2021.
- Funds reported $74.4M of Cytosorbents Corp stock for Q4 2021, down 50% quarter-over-quarter.
- 14 funds opened new Cytosorbents Corp positions in Q4 2021 and 19 closed out, a net change of -5 holders.
- The largest Cytosorbents Corp buyer in Q4 2021 was Avenir Corporation, an estimated $2.2M added.
- The largest Cytosorbents Corp seller in Q4 2021 was Soleus Capital Management, an estimated $6.5M sold.
Based on aggregated 13F filings for Q4 2021.